SEC filing · 8-K

Neogenomics Inc: Quarterly results

NeoGenomics announced a planned CEO succession and preliminary third quarter revenue of approximately $209 million.

Filed October 5, 2026

Positive for the company

What happened

Warren Stone will become Chief Executive Officer and join the Board of Directors on January 4, 2027.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Neogenomics Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.